US EditionPublished • loading... • Updated
Scientists Warn Injectable Peptides Lack Evidence Despite Influencer Hype
FDA warns about safety risks of unapproved peptides sold online and highlights challenges in regulating compounding pharmacies amid growing consumer demand.
- This week, scientists and clinicians warned many injectable synthetic peptides sold online are unproven and pose safety risks, according to the FDA.
- Influencers and online sellers promote peptides as boosting muscle growth, immune function, and slowed aging, while many products labeled 'not for pharmaceutical use' flood a largely unregulated online market.
- Experts including Paul Knoepfler, cell and molecular biologist, warn `You must test these in clinical trials to be sure of anything positive or negative` and caution about arbitrary dosing and contamination risks.
- Regulators warn that compounding pharmacies operate under different oversight than drug manufacturers, raising quality-control concerns, though Scott Brunner says they are licensed and inspected by state boards of pharmacy.
- Some approved peptide drugs illustrate the difference, and while many peptides lack safety data, patients and clinicians advise consulting a physician and using compounding pharmacies to reduce risk.
Insights by Ground AI
17 Articles
17 Articles
Coverage Details
Total News Sources17
Leaning Left4Leaning Right2Center1Last UpdatedBias Distribution57% Left
Bias Distribution
- 57% of the sources lean Left
57% Left
L 57%
14%
R 29%
Factuality
To view factuality data please Upgrade to Premium
